Catalyst Pharm Inc (CPRX)

$3.68 0.28 (7.07%)

19:34 EST CPRX Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 377.55M

PE Ratio -17.52

EPS -0.21

Volume (Avg. Vol.) 1.75M

Day's Range 3.67 - 3.96

52-Week Range 2.55 - 5.19

Dividend & Yield N/A (N/A)

CPRX Stock Predictions, Articles, and Catalyst Pharm Inc News

From InvestorPlace
From the Web

7 Penny Stock Companies That Actually Make Money

By Mark Putrino, CMT Feb 19, 2021

Penny stocks are low price for a reason. Most presume they're destined for bankruptcy. But these seven may survive: they actually make money.

Despite Legal Drama, Catalyst Pharmaceuticals Looks Oversold

By Chris Markoch Nov 3, 2020

Catalyst Pharmaceuticals stock has been on a wild ride since its drug got FDA approval -- and despite legal drama, it may be worth the risk.

Why Catalyst Pharmaceuticals Stock Is Feeling the ‘Bern’

By Josh Enomoto, InvestorPlace Contributor Oct 20, 2020

Typically, a major clinical victory would boost names like Catalyst Pharmaceuticals stock. Unfortunately, some political rumblings and an unexpected competitor got in the way of CPRX.

9 Robinhood Stocks Flying Under the Radar

By Josh Enomoto, InvestorPlace Contributor Sep 14, 2020

Robinhood stocks have generated much attention this year, but here are some names that you may not have heard about.

4 Strong Buy Biotech Stocks With Upcoming FDA Decisions

By Harriet Lefton, Writer, TipRanks Oct 23, 2018

These biotech stocks have fast-approaching PDUFA dates. Biotechs can soar or plunge on FDA decisions. These four pharma stocks should soar.

26 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 19, 2016

The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

23 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 12, 2016

The overall ratings of 23 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").